je.st
news
Tag: presented
Whiting USA Trust I Presented A Pure Arbitrage Opportunity. Or Did It Not?
2015-02-13 15:39:11| Steel - Topix.net
A notice from Bloomberg with a change of ex-div date to March 3rd at the end of the trading day threw a wrench into the arbitrage idea. Whiting USA Trust I over the past two years has practically never traded based on the underlying expected distributions.
ELEAD1ONE Presented with Automotive Website Award
2015-01-28 09:29:04| Auto Dealers - Topix.net
The 2015 Automotive Website Awards are filled with products and services to make any dealership run smoother. The leader in dealership software solutions, ELEAD1ONE was named the winner of the CRM Superstar Award for the second consecutive year.
Tags: website
presented
automotive
award
World's First Mechanical Smart Watch and Graphene-based Thermometer Presented at CES 2015 by Linktop
2015-01-07 11:30:54| Industrial Newsroom - All News for Today
XIAMEN, China and LAS VEGAS, -- Linktop Technology is introducing its mechanical smart watch and Graphene-based products cloud thermometer to the 2015 Consumer Electronics Show (CES) in Las Vegas, Nevada (January 6-9, 2015). Mr. Bill Xu, the CEO of Linktop Technology, known for his innovative mind in the Internet...
Indium Corporation Technical Manager Presented at IPC Tianjin
2014-12-19 11:31:15| Industrial Newsroom - All News for Today
Indium Corporations Pony Liao, area technical manager for Northern China, presented at IPC Tianjin Technical Seminar on November 28. Liaos presentation, The Application of Epoxy Flux, explained the benefits of using an epoxy flux for reinforcing CSP, BGA, flip-chip, and PoP assemblies to improve mobile phone...
Tags: manager
technical
presented
corporation
Data Investigating KEYTRUDA (pembrolizumab), Mercks Anti-PD-1 Therapy, in Patients with Advanced Triple-Negative Breast Cancer Presented at 2014 San Antonio Breast Cancer Symposium
2014-12-10 14:30:00| Merck.com - Corporate News
Dateline City: SAN ANTONIO 18.5 Percent Overall Response Rate Observed in KEYTRUDA-Treated Patients with This Aggressive Form of Breast Cancer Phase 2 Study Planned for the First Half of 2015 (KEYNOTE-086) SAN ANTONIO--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today early study findings demonstrating an overall response rate of 18.5 percent with KEYTRUDA, the companys anti-PD-1 therapy, as assessed by RECIST v1.1, central review (n=5/27), in PD-L1 positive, advanced triple-negative breast cancer one of the most aggressive forms of breast cancer. Language: English Contact: MerckMedia:Pamela Eisele, (267) 305-3558Claire Mulhearn, (908) 236-1118orInvestor:Joseph Romanelli, (908) 740-1986Justin Holko, (908) 740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: data
advanced
san
presented
Sites : [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] next »